Melanotan II

Description

Melanotan II – research-grade investigational peptide

Melanotan II, also known as MT-II or MT2, is a synthetic cyclic analogue of alpha-melanocyte-stimulating hormone, commonly abbreviated as α-MSH. It acts as a potent, non-selective agonist at several melanocortin receptors. Because of this receptor activity, Melanotan II is discussed in scientific research involving melanocortin signalling, pigmentation pathways, appetite-related mechanisms and neuroendocrine responses.

Within laboratory, preclinical and limited early clinical research contexts, Melanotan II is of interest due to its interactions with melanocortin receptor systems. This makes it relevant for studies examining melanogenesis, receptor-mediated cellular signalling, behavioural responses and other biological processes regulated by the melanocortin system.

Research relevance of Melanotan II

Melanotan II is commonly associated with:

• Investigation of melanocortin receptor signalling
• Studies involving melanogenesis and pigmentation pathways
• Experimental analysis of α-MSH-related biological activity
• Research into appetite, energy-balance and behavioural signalling
• Investigation of neuroendocrine and reproductive-response pathways

Scientific research background

Scientific studies examining Melanotan II have investigated its activity as a cyclic melanocortin receptor agonist. Early human research evaluated changes in pigmentation, while separate studies examined melanocortin-mediated sexual and neuroendocrine responses. Laboratory and animal research has also explored feeding behaviour, neural signalling and other melanocortin-regulated processes.

The available evidence is limited, and Melanotan II is not an authorised medicinal product. Results depend on the experimental model, research conditions, concentration, formulation, methodology and measured endpoints. Research findings should not be interpreted as confirmation that independently supplied material is safe, effective or suitable for use in humans.

The Health Products Regulatory Authority has warned that Melanotan II products are unauthorised and may present serious health risks. Official safety information notes concerns including new or darkened moles and freckles, visual problems, muscle tremors, stroke and severe allergic reactions. The FDA has additionally identified risks involving peptide aggregation, impurities, immunogenicity and published reports of serious adverse events.

Scientific reference

Dorr RT et al. Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences, 1996.

FOR RESEARCH USE ONLY

IMPORTANT INFORMATION

• This substance is supplied strictly for laboratory research purposes.
• It is not a food product.
• It is not a dietary supplement.
• It is not a cosmetic or self-tanning product.
• It is not an authorised medicinal product.
• It is not intended for human or animal consumption.
• It is not intended for injection, nasal administration or topical application.
• It must not be represented as protection against sunlight or ultraviolet exposure.
• The product name does not by itself confirm identity, purity, concentration or sterility.
• Keep out of reach of children.
• Keep the container sealed when not in use.
• Store in the original container only.
• Store according to the conditions stated on the product label or certificate of analysis.
• Protect from moisture, excessive heat and direct sunlight.
• Avoid handling during pregnancy or breastfeeding.

In the event of accidental exposure, irritation, illness or any adverse reaction, seek medical advice.